Table 3.
Comparison of the adverse events in the full analysis set
Adverse events | Treatment group | Control group | p value |
---|---|---|---|
Total | 65 (45.8%) | 77 (54.2%) | 0.154 |
Abnormal liver function | 32(22.5%) | 32(22.5%) | 1.000 |
Renal dysfunction | 8 (5.6%) | 11 (7.7%) | 0.476 |
Headache | 1 (0.7%) | 1 (0.7%) | 1.000 |
Nausea | 6 (4.2%) | 5 (3.5%) | 0.758 |
Vomiting | 2 (1.4%) | 3 (2.1%) | 0.652 |
Diarrhea | 8 (5.6%) | 19 (13.4%) | 0.026 |
Loss of appetite | 8 (5.6%) | 6 (4.2%) | 0.584 |